Multidrug-resistant Mycobacterium tuberculosis (MDR-TB) is a leading cause of morbidity and mortality in the Philippines. The purpose of this study was to gain knowledge about the relationship between potential risk factors and MDR-TB. Risk factors (the independent variables) for MDR-TB (the dependent variable) include previous TB treatment, infection with HIV, exposure to patients with drug-susceptible TB/MDR-TB, delays in diagnosis and treatment, employment status, smoking, imprisonment, alcohol abuse, and poor compliance with TB treatment regimens. The study was based on the epidemiological approach to causal inference work. A case-control study design was used wherein a quantitative method was applied in data analysis to assess the stre...
Background: this study aimed to assess the drug resistant pattern of Mycobacterium tuberculosis comp...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
Multidrug-Resistant Tuberculosis (MDR-TB) is the biggest problem in the prevention and eradication o...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Globally, the issue of Multidrug Resistant Tuberculosis (MDR-TB) was acknowledged as a threat to the...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
The purpose of this study was to establish empirical evidence on risk factors influencing drug-resis...
Background: Tuberculosis, often known as TB, is a disease caused by an infection with the bacteria M...
Objective: Indonesia has one of the highest burdens of multidrug-resistant tuberculosis (MDR-TB), wi...
Tuberculosis (TB) is a leading public health problem across the world. For various reasons, TB and m...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global concern including in Indonesia. Th...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Background: Multidrug resistant tuberculosis(MDR-TB) is becoming a major threat to tuberculosis cont...
Background: Tuberculosis (TB) is a growing global health problem, with increasing evidence of multid...
Background: this study aimed to assess the drug resistant pattern of Mycobacterium tuberculosis comp...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
Multidrug-Resistant Tuberculosis (MDR-TB) is the biggest problem in the prevention and eradication o...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Globally, the issue of Multidrug Resistant Tuberculosis (MDR-TB) was acknowledged as a threat to the...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
The purpose of this study was to establish empirical evidence on risk factors influencing drug-resis...
Background: Tuberculosis, often known as TB, is a disease caused by an infection with the bacteria M...
Objective: Indonesia has one of the highest burdens of multidrug-resistant tuberculosis (MDR-TB), wi...
Tuberculosis (TB) is a leading public health problem across the world. For various reasons, TB and m...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global concern including in Indonesia. Th...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
Background: Multidrug resistant tuberculosis(MDR-TB) is becoming a major threat to tuberculosis cont...
Background: Tuberculosis (TB) is a growing global health problem, with increasing evidence of multid...
Background: this study aimed to assess the drug resistant pattern of Mycobacterium tuberculosis comp...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
Multidrug-Resistant Tuberculosis (MDR-TB) is the biggest problem in the prevention and eradication o...